Ignite Creation Date:
2025-12-25 @ 3:04 AM
Ignite Modification Date:
2026-05-17 @ 5:43 PM
Study NCT ID:
NCT03189433
Status:
TERMINATED
Last Update Posted:
2021-03-30
First Post:
2017-06-14
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Efficacy and Safety Study of Ryanodex as Adjuvant Treatment in Subjects With Psychostimulant Drug-Induced Toxicity (PDIT)
Sponsor:
Eagle Pharmaceuticals, Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
EGL-4104-C-1702
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None